University of Groningen, Netherlands
Efficacy of influenza vaccine is decreased in systemic lupus erythematosus patients
Published in Law and Health Weekly, August 12th, 2006
Scientists in the Netherlands conducted a study "to assess the safety and efficacy of influenza vaccination in patients with systemic lupus erythematosus (SLE), and to evaluate the influence of immunosuppressive drugs on the immune response."
Bert Holvast and colleagues at the University of Groningen explained, "SLE patients (n=56) and healthy controls (n=18) were studied. All patients had quiescent disease (SLE disease activity index {{<=}}5). Four patient groups were defined on the basis of their drug use: no drug treatment;...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- American Medical Association
Anti-retroviral therapies associated with reduced infections in HIV-infected children - Aradigm
Aradigm and Novo Nordisk execute further restructuring of partnership - Columbia University, U.S.
Researchers discover a protein in nerve cells that acts as a switch for chronic pain - Cozart
Cozart secures U.S. patent for lead products RapiScan and DDS - Harvard University
Recent findings from the United States illuminate research in vectors - Market Analysis
Medicare plans average 88 drugs in formularies while private plans have 15 to 20, report says - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
